EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY

被引：0
|
作者：
Saliba, F. [1 ]
Duvoux, C. [2 ]
Durand, F. [3 ]
Neau-Cransac, M. [4 ]
Hardwigsen, J. [5 ]
Pageaux, G. [6 ]
Di Giambattista, F. [7 ]
机构：
[1] Hop Paul Brousse, Villejuif, France
[2] Hop Henri Mondor, F-94010 Creteil, France
[3] Hop Beaujon, Clichy, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Conception, Marseille, France
[6] Hop St Eloi, Montpellier, France
[7] Novartis Pharma SAS, Rueil Malmaison, France
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
74
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [11] Effects of Everolimus and Tacrolimus Exposure on Efficacy and Renal Function in Liver Transplant Recipients at 24 Months in a Randomized Trial (H2304)
    Fischer, L.
    Kaiser, G.
    Koneru, B.
    Toselli, L.
    Durand, F.
    Heaton, N.
    Shetty, K.
    Dong, G.
    Lopez, P.
    Junge, G.
    Kovarik, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 117 - 118
  • [12] Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 238 - 238
  • [13] Efficacy and Safety of Everolimus in De Novo Liver Transplant Recipients-12 Month Results of a Randomized, Multicenter Study.
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    LIVER TRANSPLANTATION, 2012, 18 : S109 - S110
  • [14] Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    Metselaar, H. J.
    Saliba, F.
    Schemmer, P.
    Foltys, D.
    Fabregat, J.
    Ericzon, B. -G.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    TRANSPLANTATION, 2012, 94 (10) : 44 - 44
  • [15] Long-Term Superior Renal Function With Everolimus and Reduced Tacrolimus in Liver Transplant Recipients: 3-Year Results from the H2304 Extension Study
    Fischer, Lutz
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    Nevens, Frederik
    Duvoux, Christophe
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    LIVER TRANSPLANTATION, 2014, 20 : S171 - S172
  • [16] Long-Term Safety With Everolimus-Based Regimen in De Novo Liver Transplant Recipients: 4-Year Results From The Extension of H2304 Study.
    Saliba, F.
    Rogiers, X.
    Chapman, W.
    Caicedo, L.
    Alsina, A.
    Teperman, L.
    Junge, G.
    Rauer, B.
    Dong, G.
    De Simone, P.
    TRANSPLANTATION, 2014, 98 : 161 - 161
  • [17] Impact of Everolimus-Based Immunosuppression on Efficacy, Safety and Progression of Fibrosis in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 12 Months Results from H2304 Study
    Beckebaum, S.
    Chavin, K. D.
    Teperman, L.
    Wiederkehr, J.
    Trunecka, P.
    Dong, G.
    Junge, G.
    Lopez, P.
    Duvoux, C.
    TRANSPLANTATION, 2012, 94 (10) : 8 - 8
  • [18] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Jiang, Hai
    Junge, Guido
    HEPATOLOGY, 2011, 54 : 1430A - 1431A
  • [19] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
    Weymann, A.
    Ganschow, R.
    Ericzon, B.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
  • [20] Long-Term Safety With Everolimus-Based Regimen in De Novo Liver Transplant Recipients: 4-Year Results From The Extension of H2304 Study.
    Saliba, F.
    Rogiers, X.
    Chapman, W.
    Caicedo, L.
    Alsina, A.
    Teperman, L.
    Junge, G.
    Rauer, B.
    Dong, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 161 - 161
12345